Knight Therapeutics | GUD - Ebitda

股票价格

7.56

每天变化

-0.09 -1.18%

每月一次

22.13%

每年

35.24%

Q2 预测

7.26

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 771.93M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	Ebitda	更改		日
Acasti Pharma	USD -2.45M		735K	2025-12
Akebia Therapeutics	USD 14.03M		17.19M	2025-03
Alaunos Therapeutics	USD -21.02M		1.33M	2021-03
Aurora Cannabis	CAD 18.48M		3.11M	2025-12
Avita Medical	AUD -9.69M		12.21M	2025-12
Canopy Growth	CAD -2.87M		19.49M	2025-12
Cronos Group	USD 456K		5.22M	2025-12
Dianthus Therapeutics	USD -40.19M		5.36M	2025-09
Ionis Pharmaceuticals	USD -157.12M		307.36M	2025-09
IQVIA Holdings	USD 1.05B		97M	2025-12
Knight Therapeutics	CAD 24.45M		3.46M	2025-12
Moderna	USD -790M		582M	2025-12
Omeros	USD -47.96M		7.39M	2023-09
Organigram Holdings	CAD 5.26M		884K	2025-12
Organon & Co	USD 383M		135M	2025-12
Revvity	USD 248.91M		48.52M	2025-12
Tectonic Therapeutic	USD -21.18M		365K	2025-12
Tilray	USD 8.36M		1.82M	2025-09
Viatris	USD 1B		151.5M	2025-12
Xeris Pharmaceuticals	USD 25.09M		7.67M	2025-12